Organisation paid for research Program year 2023 Source: CMS Open Payments

Arthritis Consultants

Neither a doctor nor a teaching hospital

Research payments

$28,829

12 payments

Through program year 2023, Arthritis Consultants is reported as receiving $28,829 in research payments, across 12 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$1,975	2
2022	Research	$13,775	4
2021	Research	$4,814	2
2020	Research	$4,142	1
2019	Research	$4,124	3

Breakdown

Who paid Research payments · program years 2019–2023

E.R. Squibb & Sons, L.L.C. $19,317 5 payments
GlaxoSmithKline, LLC. $5,388 4 payments
AbbVie, Inc. $4,124 3 payments

Studies the money was for Research payments · program years 2019–2023

Phase II Study SLE - A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BMS-986256 in Participants with Active Systemic Lupus Erythematosus $10,000 1 payment
PhIIIb Early Arthritis AVERT2 $8,864 2 payments
M13-549 $4,124 3 payments
A 24-Week, Phase 3, Multicentre, Randomised, Double-Blind, Efficacy An $3,413 2 payments
A 52-Week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy An $1,659 1 payment
AMPLIFIED - A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Cl $362 1 payment
A Multi-Centre Long-Term Extension Study to Assess the Safety and Effi $316 1 payment
AMPLIFIED Study $91 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.